Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup

O. Sokol, AT. Frederiksen, M. Sitarz, BS. Sørensen, E. Santina, C. Smith, JW. Warmenhoven, M. Davídková, AJ. Michaelidesová, I. Danilová, O. Zahradníček, AM. Leite, L. de Marzi, F. Pouzoulet, P. Olko, J. Miszczyk, B. Orzechowska, E. Papalanis, M....

. 2025 ; 53 (-) : 100978. [pub] 20250511

Status neindexováno Jazyk angličtina Země Irsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25014111

BACKGROUND AND PURPOSE: This study presents a multi-center comparison of in vitro cell survival measurements and RBE calculations following proton irradiations conducted under harmonized experimental conditions across six European institutions participating in the INSPIRE framework. MATERIALS AND METHODS: V79-4 cells were irradiated using spread-out Bragg peak (SOBP) proton fields of two configurations delivering 6 and 8 Gy with widths of 6 and 4 cm, respectively. Each center adhered to a standardized protocol, utilizing the same phantom design to minimize uncertainties related to sample positioning. X-ray reference irradiations were also performed to assess cell radiosensitivity across the participating centers. RESULTS: Despite the consistent protocol, significant inter-institutional variability was observed in the survival measurements. For both treatment plans, the largest variation was detected in the most distal points of the SOBP (coefficients of variation of 43 % and 60 % for the 6 Gy and 8 Gy plans, respectively). Kruskal-Wallis statistical test confirmed the significant differences between the centers for each of the measured position in the proton field for both SOBP configurations. Discrepancies were observed in calculated RBE data as well, albeit preserving the expected trend for the values to slightly increase towards the distal edge of the SOBP (up to 1.5 and 1.3 for the 6 Gy and 8 Gy plans, respectively). CONCLUSION: The results of the study highlight the minimal biological variation one could expect performing proton RBE measurements in well-aligned experimental conditions and challenges in conducting large-scale, multi-center radiobiological experiments and inter-comparisons between literature data sets.

CIMAP CEA CNRS ENSICAEN UNICAEN Normandie Université Caen France

Danish Centre for Particle Therapy Aarhus University Hospital Aarhus Denmark

Department of Experimental Clinical Oncology Aarhus University Hospital Aarhus Denmark

Department of Immunology Genetics and Pathology Uppsala University Uppsala Sweden

Department of Radiotherapy and Radiation Oncology Faculty of Medicine and University Hospital Carl Gustav Carus Technische Universität Dresden Dresden Germany

Division of Cancer Sciences Faculty of Biology Medicine and Health The University of Manchester Manchester UK

GSI Helmholtz Centre for Heavy Ion Research Darmstadt Germany

Helmholtz Zentrum Dresden Rossendorf Institute of Radiation Physics Dresden Germany

Helmholtz Zentrum Dresden Rossendorf Institute of Radiooncology OncoRay Dresden Germany

Inserm U1021 CNRS UMR 3347 Institut Curie PSL Research University University Paris Saclay Orsay France

Inserm U1288 Laboratory of Translational Imaging in Oncology Institut Curie PSL Research University University Paris Saclay Orsay France

Institut Curie PSL Research University Radiation Oncology Department Proton Therapy Centre Centre universitaire Orsay France

Institute for Condensed Matter Physics Technische Universität Darmstadt Darmstadt Germany

Institute of Nuclear Physics Polish Academy of Sciences Krakow Poland

Manchester Academic Health Science Centre The Christie NHS Foundation Trust Manchester UK

Nuclear Physics Institute of the Czech Academy of Sciences Řež Czech Republic

OncoRay National Center for Radiation Research in Oncology Faculty of Medicine and University Hospital Carl Gustav Carus Technische Universität Dresden Helmholtz Zentrum Dresden Rossendorf Dresden Germany

OncoRay National Center for Radiation Research in Oncology Faculty of Medicine Dresden Germany

The Skandion Clinic Uppsala Sweden

Translational Research Department Institut Curie Experimental Radiotherapy Platform University Paris Saclay Orsay France

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25014111
003      
CZ-PrNML
005      
20250905141501.0
007      
ta
008      
250701e20250511ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ctro.2025.100978 $2 doi
035    __
$a (PubMed)40485910
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Sokol, Olga $u GSI Helmholtz Centre for Heavy Ion Research, Darmstadt, Germany
245    10
$a In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup / $c O. Sokol, AT. Frederiksen, M. Sitarz, BS. Sørensen, E. Santina, C. Smith, JW. Warmenhoven, M. Davídková, AJ. Michaelidesová, I. Danilová, O. Zahradníček, AM. Leite, L. de Marzi, F. Pouzoulet, P. Olko, J. Miszczyk, B. Orzechowska, E. Papalanis, M. Hariri, D. Spiegelberg, B. Stenerlöw, A. Dasu, E. Bodenstein, E. Beyreuther, J. Pawelke, D. Pfitzmann, K. Kirkby, N. Henthorn, M. Durante
520    9_
$a BACKGROUND AND PURPOSE: This study presents a multi-center comparison of in vitro cell survival measurements and RBE calculations following proton irradiations conducted under harmonized experimental conditions across six European institutions participating in the INSPIRE framework. MATERIALS AND METHODS: V79-4 cells were irradiated using spread-out Bragg peak (SOBP) proton fields of two configurations delivering 6 and 8 Gy with widths of 6 and 4 cm, respectively. Each center adhered to a standardized protocol, utilizing the same phantom design to minimize uncertainties related to sample positioning. X-ray reference irradiations were also performed to assess cell radiosensitivity across the participating centers. RESULTS: Despite the consistent protocol, significant inter-institutional variability was observed in the survival measurements. For both treatment plans, the largest variation was detected in the most distal points of the SOBP (coefficients of variation of 43 % and 60 % for the 6 Gy and 8 Gy plans, respectively). Kruskal-Wallis statistical test confirmed the significant differences between the centers for each of the measured position in the proton field for both SOBP configurations. Discrepancies were observed in calculated RBE data as well, albeit preserving the expected trend for the values to slightly increase towards the distal edge of the SOBP (up to 1.5 and 1.3 for the 6 Gy and 8 Gy plans, respectively). CONCLUSION: The results of the study highlight the minimal biological variation one could expect performing proton RBE measurements in well-aligned experimental conditions and challenges in conducting large-scale, multi-center radiobiological experiments and inter-comparisons between literature data sets.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Frederiksen, Anders Tobias $u Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark $u Danish Centre for Particle Therapy (DCPT), Aarhus University Hospital, Aarhus Denmark
700    1_
$a Sitarz, Mateusz $u Danish Centre for Particle Therapy (DCPT), Aarhus University Hospital, Aarhus Denmark $u CIMAP, CEA-CNRS-ENSICAEN-UNICAEN, Normandie Université, Caen, France
700    1_
$a Sørensen, Brita Singers $u Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark $u Danish Centre for Particle Therapy (DCPT), Aarhus University Hospital, Aarhus Denmark
700    1_
$a Santina, Elham $u Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK $u Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK
700    1_
$a Smith, Christopher $u Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK $u Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK
700    1_
$a Warmenhoven, John-William $u Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK $u Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK
700    1_
$a Davídková, Marie $u Nuclear Physics Institute of the Czech Academy of Sciences, Řež, Czech Republic
700    1_
$a Michaelidesová, Anna Jelínek $u Nuclear Physics Institute of the Czech Academy of Sciences, Řež, Czech Republic
700    1_
$a Danilová, Irina $u Nuclear Physics Institute of the Czech Academy of Sciences, Řež, Czech Republic
700    1_
$a Zahradníček, Oldřich $u Nuclear Physics Institute of the Czech Academy of Sciences, Řež, Czech Republic
700    1_
$a Leite, Amélia Maia $u Inserm U1021 - CNRS UMR 3347, Institut Curie, PSL Research University, University Paris Saclay, Orsay, France $u Institut Curie, PSL Research University, Radiation Oncology Department, Proton Therapy Centre, Centre universitaire, Orsay, France
700    1_
$a de Marzi, Ludovic $u Institut Curie, PSL Research University, Radiation Oncology Department, Proton Therapy Centre, Centre universitaire, Orsay, France $u Inserm U1288, Laboratory of Translational Imaging in Oncology (LITO), Institut Curie, PSL Research University, University Paris Saclay, Orsay, France
700    1_
$a Pouzoulet, Frederic $u Inserm U1288, Laboratory of Translational Imaging in Oncology (LITO), Institut Curie, PSL Research University, University Paris Saclay, Orsay, France $u Translational Research Department, Institut Curie, Experimental Radiotherapy Platform, University Paris Saclay, Orsay, France
700    1_
$a Olko, Paweł $u Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
700    1_
$a Miszczyk, Justyna $u Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
700    1_
$a Orzechowska, Barbara $u Institute of Nuclear Physics Polish Academy of Sciences, Krakow, Poland
700    1_
$a Papalanis, Eleftherios $u Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
700    1_
$a Hariri, Mehran $u Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
700    1_
$a Spiegelberg, Diana $u Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
700    1_
$a Stenerlöw, Bo $u Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
700    1_
$a Dasu, Alexandru $u Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden $u The Skandion Clinic, Uppsala, Sweden
700    1_
$a Bodenstein, Elisabeth $u Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Institute of Radiooncology - OncoRay, Dresden, Germany $u OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany
700    1_
$a Beyreuther, Elke $u OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany $u Helmholtz-Zentrum Dresden - Rossendorf, Institute of Radiation Physics, Dresden, Germany
700    1_
$a Pawelke, Jörg $u Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Institute of Radiooncology - OncoRay, Dresden, Germany $u OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany
700    1_
$a Pfitzmann, Dorothee $u Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany $u OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine, Dresden, Germany
700    1_
$a Kirkby, Karen $u Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK $u Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK
700    1_
$a Henthorn, Nicholas $u Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK $u Manchester Academic Health Science Centre, The Christie NHS Foundation Trust, Manchester, UK
700    1_
$a Durante, Marco $u GSI Helmholtz Centre for Heavy Ion Research, Darmstadt, Germany $u Institute for Condensed Matter Physics, Technische Universität Darmstadt, Darmstadt, Germany
773    0_
$w MED00213969 $t Clinical and translational radiation oncology $x 2405-6308 $g Roč. 53 (20250511), s. 100978
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40485910 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250701 $b ABA008
991    __
$a 20250905141448 $b ABA008
999    __
$a ok $b bmc $g 2387966 $s 1251231
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2025 $b 53 $c - $d 100978 $e 20250511 $i 2405-6308 $m Clinical and translational radiation oncology $n Clin Transl Radiat Oncol $x MED00213969
LZP    __
$a Pubmed-20250701

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...